Comparing the Diagnostic Efficacy of 99m Tc-PSMA SPECT/CT Scanning After 75 Minutes and 4 Hours of Radiotracer Injection in Men with Prostate Cancer

被引：0
|
作者：
Aghaee, A. [1 ]
Sahebkari, A. [1 ]
Soltani, S. [2 ]
Ghorbani, H. [2 ]
Aryana, K. [1 ]
Sadri, K. [1 ]
机构：
[1] Mashhad Univ Med Sci, Inuclear Med Res Ctr, Mashhad, Iran
[2] Mashhad Univ Med Sci, Kidney Translantat Res Ctr, Mashhad, Iran
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2023年 / 50卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
EP-0264
引用
收藏
页码：S536 / S536
页数：1
相关论文
共 17 条
  • [1] Comparing the diagnostic efficacy of [99mTc]Tc-HYNIC-PSMA-11 SPECT/CT scanning after 75 minutes and 4 hours of radiotracer injection in men with prostate cancer
    Sahebkari, Azadeh
    Soltani, Salman
    Ghorbani, Hamidreza
    Aryana, Kamran
    Kabiri, Mona
    Sadri, Kayvan
    Mottaghi, Mahdi
    Aghaee, Atena
    IRANIAN JOURNAL OF NUCLEAR MEDICINE, 2024, 32 (01): : 9 - 15
  • [2] Diagnostic efficacy of [99mTc]Tc-PSMA SPECT/CT for prostate cancer: a meta-analysis
    Wang, Qi
    Ketteler, Svea
    Bagheri, Shamim
    Ebrahimifard, Ali
    Luster, Markus
    Librizzi, Damiano
    Yousefi, Behrooz H.
    BMC CANCER, 2024, 24 (01)
  • [3] Diagnostic performance of Tc-99m PSMA-11 SPECT- CT in prostate carcinoma
    Agrawal, K.
    Satpati, D.
    Nayak, P.
    Sable, M.
    Padhy, B. M.
    Kumar, N.
    Parida, G. K.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2022, 49 (SUPPL 1) : S502 - S502
  • [4] An Australian experience using Tc-PSMA SPECT/CT in the primary diagnosis of prostate cancer and for staging at biochemical recurrence after local therapy
    Duncan, Iain
    Ingold, Nicholas
    Martinez-Marroquin, Elisa
    Paterson, Catherine
    PROSTATE, 2023, 83 (10): : 970 - 979
  • [5] Radiation Dosimetry analysis of 99m Tc-Hynic-PSMA-11 in prostate cancer patients for diagnostic scintigraphy
    Kumar, J.
    Shukla, V.
    Chauhan, M.
    Gupta, S.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 51 : S797 - S798
  • [6] Tc-99m-PSMA-SPECT/CT Is Superior to Tc-99m-MDP-SPECT/CT in the Staging of Prostatic Cancer with Osseous Metastases after External Beam Radiotherapy
    Liepe, Knut
    Baehr, Marcel
    WORLD JOURNAL OF NUCLEAR MEDICINE, 2022, 21 (01) : 62 - 64
  • [7] Diagnostic sensitivity of Tc-99m HYNIC PSMA SPECT/CT in prostate carcinoma: A comparative analysis with Ga-68 PSMA PET/CT
    Lawal, Ismaheel O.
    Ankrah, Alfred O.
    Mokgoro, Neo P.
    Vorster, Mariza
    Maes, Alex
    Sathekge, Mike M.
    PROSTATE, 2017, 77 (11): : 1205 - 1212
  • [8] Diagnostic value of [99mTc]Tc-PSMA-I&S-SPECT/CT for the primary staging and restaging of prostate cancer
    Farkas, Istvan
    Sipka, Gabor
    Bakos, Annamaria
    Maraz, Aniko
    Bajory, Zoltan
    Miko, Zsofia
    Czekus, Tamas
    Urban, Szabolcs
    Varga, Linda
    Pavics, Laszlo
    Besenyi, Zsuzsanna
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2024, 16
  • [9] [99mTc]Tc-PSMA-T4 a potential radiofarmaceutical for SPECT/CT imaging of metastatic prostate cancer
    Wojdowska, Wioletta
    Maurin, Michal
    Sikora, Arkadiusz
    Janota, Barbara
    Radzik, Marcin
    Sawicka, Agnieszka
    Pijarowska-Kruszyna, Justyna
    Garnuszek, Piotr
    Karczmarczyk, Urszula
    NUCLEAR MEDICINE AND BIOLOGY, 2023, 126 : S106 - S107
  • [10] Tc-99m labeled PSMA-617 as a potential SPECT radiotracer for prostate cancer diagnostics: Complexation optimization and its in vitro/ vivo evaluation
    Tachatumvitoon, Kalapaphuk
    Preuksarattanawut, Charasphat
    Tippayamontri, Thititip
    Khomein, Piyachai
    BIOORGANIC & MEDICINAL CHEMISTRY, 2025, 118
12